Performance analysis of Astria Therapeutics (ATXS)
Annual Return
Over the past 3 years, ATXS has had an average annual return of +3.78%, underperforming the benchmark SPY, which returned +21.52% annual.
Over the past 5 years, ATXS has had an average annual return of +0.82%, underperforming the benchmark SPY, which returned +12.75% annual.
Over the past 10 years, ATXS has had an average annual return of -30.33%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Jun 25, 2015, ATXS has had an average annual return of -32.29%, underperforming the benchmark SPY, which returned +13.78% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.17% | +46.09% | +17.35% | -48.69% | +176.81% | -58.18% | -63.74% | +35.42% | -70.68% | -58.73% | -54.48% | -39.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.17% | -4.17% | |||||||||||
| 2025 | -12.17% | -17.82% | -18.07% | -2.94% | -7.58% | +13.11% | +28.99% | -11.24% | +17.72% | +74.19% | +0% | +3.70% | +46.09% |
| 2024 | +70.41% | +8.98% | -1.10% | -34.44% | +2.54% | -3.31% | +28.21% | +4.67% | -10.19% | +1.42% | -6.99% | -13.53% | +17.35% |
| 2023 | -7.85% | -11.36% | +9.62% | -2.34% | -16.17% | -23.57% | +7.48% | -0.87% | -15.79% | -33.33% | -6.25% | +63.33% | -48.69% |
| 2022 | -7.25% | +35.94% | -1.15% | -9.30% | -39.74% | -19.15% | +39.47% | +107.55% | +5.45% | +6.03% | +4.88% | +48.06% | +176.81% |
| 2021 | +93.33% | -30.41% | -0% | -22.07% | -9.25% | +3.18% | -22.84% | +2.40% | -11.72% | -19.47% | -9.89% | -15.85% | -58.18% |
| 2020 | -10.33% | -8.09% | -14.93% | +36.68% | +9.63% | +3.56% | -10.10% | +14.16% | -6.30% | -78.36% | +23.30% | +29.92% | -63.74% |
| 2019 | +45.83% | -24.29% | +64.15% | -5.09% | -8.65% | +17.61% | -12.24% | -12.84% | -12.63% | -6.02% | +11.54% | +4.60% | +35.42% |
| 2018 | +0% | +15.45% | +5.22% | -10.49% | +7.38% | -44.84% | -28.05% | +2.82% | +12.64% | -19.51% | -3.23% | -29.85% | -70.68% |
| 2017 | +11.92% | -70.30% | +33.37% | -10.64% | -6.27% | +5.24% | -14.19% | +13.21% | +54.74% | -3.80% | -13.19% | -15.86% | -58.73% |
Drawdown analysis of Astria Therapeutics (ATXS)
The maximum drawdown for the ATXS was -99.71%, occurring on Jun 14, 2022. This drawdown has not yet recovered.
The current ATXS drawdown is -98.56%.
Since Jun 25, 2015 ATXS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.71% | Jul 23, 2015 | 1736 | Jun 14, 2022 | Ongoing | Ongoing | Ongoing |
| -13.11% | Jun 26, 2015 | 1 | Jun 29, 2015 | 4 | Jul 6, 2015 | 5 |
| -9.94% | Jul 10, 2015 | 1 | Jul 13, 2015 | 8 | Jul 23, 2015 | 9 |
| -7.99% | Jul 6, 2015 | 3 | Jul 9, 2015 | 1 | Jul 10, 2015 | 4 |